Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Therefore, fighting against such cancer is reasonable. Chemotherapy drugs are sometimes inefficient and often accompanied by undesirable side effects for patients. On the other hand, the emergence of chemoresistant HCC em...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/13/10/719 |
| _version_ | 1797513105980260352 |
|---|---|
| author | Mohammad Heiat Hamid Hashemi Yeganeh Seyed Moayed Alavian Ehsan Rezaie |
| author_facet | Mohammad Heiat Hamid Hashemi Yeganeh Seyed Moayed Alavian Ehsan Rezaie |
| author_sort | Mohammad Heiat |
| collection | DOAJ |
| description | Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Therefore, fighting against such cancer is reasonable. Chemotherapy drugs are sometimes inefficient and often accompanied by undesirable side effects for patients. On the other hand, the emergence of chemoresistant HCC emphasizes the need for a new high-efficiency treatment strategy. Immunotoxins are armed and rigorous targeting agents that can purposefully kill cancer cells. Unlike traditional chemotherapeutics, immunotoxins because of targeted toxicity, insignificant cross-resistance, easy production, and other favorable properties can be ideal candidates against HCC. In this review, the characteristics of proper HCC-specific biomarkers for immunotoxin targeting were dissected. After that, the first to last immunotoxins developed for the treatment of liver cancer were discussed. So, by reviewing the strengths and weaknesses of these immunotoxins, we attempted to provide keynotes for designing an optimal immunotoxin against HCC. |
| first_indexed | 2024-03-10T06:10:02Z |
| format | Article |
| id | doaj.art-ffeaa8b040834797996db44a84a66b42 |
| institution | Directory Open Access Journal |
| issn | 2072-6651 |
| language | English |
| last_indexed | 2024-03-10T06:10:02Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj.art-ffeaa8b040834797996db44a84a66b422023-11-22T20:13:24ZengMDPI AGToxins2072-66512021-10-01131071910.3390/toxins13100719Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising ProspectMohammad Heiat0Hamid Hashemi Yeganeh1Seyed Moayed Alavian2Ehsan Rezaie3Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Science, Tehran 1435916471, IranDepartment of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran 14115111, IranBaqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Science, Tehran 1435916471, IranMolecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Science, Tehran 1435916471, IranHepatocellular carcinoma (HCC) is one of the most common cancers in the world. Therefore, fighting against such cancer is reasonable. Chemotherapy drugs are sometimes inefficient and often accompanied by undesirable side effects for patients. On the other hand, the emergence of chemoresistant HCC emphasizes the need for a new high-efficiency treatment strategy. Immunotoxins are armed and rigorous targeting agents that can purposefully kill cancer cells. Unlike traditional chemotherapeutics, immunotoxins because of targeted toxicity, insignificant cross-resistance, easy production, and other favorable properties can be ideal candidates against HCC. In this review, the characteristics of proper HCC-specific biomarkers for immunotoxin targeting were dissected. After that, the first to last immunotoxins developed for the treatment of liver cancer were discussed. So, by reviewing the strengths and weaknesses of these immunotoxins, we attempted to provide keynotes for designing an optimal immunotoxin against HCC.https://www.mdpi.com/2072-6651/13/10/719immunotoxinhepatocellular carcinomatargeted therapyliver cancerdrug targeting |
| spellingShingle | Mohammad Heiat Hamid Hashemi Yeganeh Seyed Moayed Alavian Ehsan Rezaie Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect Toxins immunotoxin hepatocellular carcinoma targeted therapy liver cancer drug targeting |
| title | Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect |
| title_full | Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect |
| title_fullStr | Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect |
| title_full_unstemmed | Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect |
| title_short | Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect |
| title_sort | immunotoxins immunotherapy against hepatocellular carcinoma a promising prospect |
| topic | immunotoxin hepatocellular carcinoma targeted therapy liver cancer drug targeting |
| url | https://www.mdpi.com/2072-6651/13/10/719 |
| work_keys_str_mv | AT mohammadheiat immunotoxinsimmunotherapyagainsthepatocellularcarcinomaapromisingprospect AT hamidhashemiyeganeh immunotoxinsimmunotherapyagainsthepatocellularcarcinomaapromisingprospect AT seyedmoayedalavian immunotoxinsimmunotherapyagainsthepatocellularcarcinomaapromisingprospect AT ehsanrezaie immunotoxinsimmunotherapyagainsthepatocellularcarcinomaapromisingprospect |